Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis

被引：0
|
作者：
Takafumi Yanagisawa
Tatsushi Kawada
Fahad Quhal
Kensuke Bekku
Ekaterina Laukhtina
Pawel Rajwa
Markus von Deimling
Muhammad Majdoub
Marcin Chlosta
Benjamin Pradere
Keiichiro Mori
Takahiro Kimura
Manuela Schmidinger
Pierre I. Karakiewicz
Shahrokh F. Shariat
机构：
[1] Medical University of Vienna,Department of Urology, Comprehensive Cancer Center
[2] The Jikei University School of Medicine,Department of Urology
[3] Okayama University Graduate School of Medicine,Department of Urology, Dentistry and Pharmaceutical Sciences
[4] King Fahad Specialist Hospital,Department of Urology
[5] Sechenov University,Institute for Urology and Reproductive Health
[6] Medical University of Silesia,Department of Urology
[7] University Medical Center Hamburg-Eppendorf,Department of Urology
[8] Hillel Yaffe Medical Center,Department of Urology
[9] Jagiellonian University,Clinic of Urology and Urological Oncology
[10] Department of Urology,Cancer Prognostics and Health Outcomes Unit, Division of Urology
[11] La Croix Du Sud Hospital,Division of Urology, Department of Special Surgery
[12] University of Montreal Health Center,Department of Urology
[13] The University of Jordan,Department of Urology, Second Faculty of Medicine
[14] University of Texas Southwestern Medical Center,Department of Urology
[15] Charles University,undefined
[16] Weill Cornell Medical College,undefined
[17] Karl Landsteiner Institute of Urology and Andrology,undefined
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Sex; Gender; Immune checkpoint inhibitors; Renal cell carcinoma; Urothelial carcinoma; Metastatic; Advanced; Adjuvant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1763 / 1774
页数：11
相关论文
共 50 条
  • [41] Efficacy and toxicity of neoadjuvant immune checkpoint inhibitors in resectable gastric cancer: A meta-analysis and systematic review
    Li, Song
    Xu, Qian
    Dai, Xin
    Zhang, Xue
    Huang, Miao
    Huang, Kai
    Wang, Jian
    Chu, Jiahui
    Liu, Lian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [42] A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer
    El Helali, Aya
    Tao, Jun
    Wong, Charlene H. L.
    Chan, Wendy Wing-Lok
    Mok, Ka-Chun
    Wu, Wing Fong
    Shitara, Kohei
    Mohler, Markus
    Boku, Narikazu
    Pang, Herbert
    Lam, Ka On
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis
    Jingjie Chen
    Shengnan Li
    Qigu Yao
    Nannan Du
    Xiaojun Fu
    Yuanmei Lou
    Mengru Wang
    Feiyan Mao
    Danyi Mao
    Parikshit Asutosh Khadaroo
    Yingying Tang
    World Journal of Surgical Oncology, 18
  • [44] Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
    Leite da Silva, Luis Felipe
    Siegloch Barros, Maria Luisa
    da Silva, Raul Vinicius
    Rodrigues, Farley Reis
    Vilbert, Maysa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
    Park, Eun-Joo
    Park, Hyo-Jung
    Kim, Kyung-Won
    Suh, Chong-Hyun
    Yoo, Changhoon
    Chae, Young-Kwang
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    CANCERS, 2022, 14 (03)
  • [46] Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
    Zou, Yutian
    Zou, Xuxiazi
    Zheng, Shaoquan
    Tang, Hailin
    Zhang, Lijuan
    Liu, Peng
    Xie, Xiaoming
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [47] Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta-Analysis
    Xu, Huijun
    Yang, Yang
    Yan, Ying
    Li, Mengge
    Wu, Shusheng
    Cao, Lulu
    Chen, Wenju
    Luo, Huiqin
    He, Yifu
    CANCER MEDICINE, 2024, 13 (20):
  • [48] Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis
    Yu, Hang
    Liu, Qingquan
    Wu, Keting
    Tang, Shuang
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [49] The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis
    Chen, Jingjie
    Li, Shengnan
    Yao, Qigu
    Du, Nannan
    Fu, Xiaojun
    Lou, Yuanmei
    Wang, Mengru
    Mao, Feiyan
    Mao, Danyi
    Khadaroo, Parikshit Asutosh
    Tang, Yingying
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [50] Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis
    Xia, Handai
    Zhang, Wengang
    Zhang, Yuqing
    Shang, Xiaoling
    Liu, Yanguo
    Wang, Xiuwen
    FRONTIERS IN ONCOLOGY, 2022, 12
12345